Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PRPH | US
0.06
2.50%
Healthcare
Drug Manufacturers - Major
30/06/2024
04/10/2024
2.46
2.37
2.48
2.35
ProPhase Labs Inc. engages in the development and commercialization of novel drugs dietary supplements and compounds in the United States. The company operates in two segments Diagnostic Services and Consumer Products. It provides a range of OTC dietary supplements including Legendz XL for male sexual health; and Triple Edge XL an energy and stamina booster. The company also offers contract manufacturing services such as consumer product development pre-commercialization production warehousing and distribution; COVID-19 diagnostic information services to a range of customers including health plans third party payers and government organizations; and respiratory pathogen panel molecular testing services as well as personal genomics products and services. In addition it is involved in the research development manufacture distribution marketing and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs Inc. was founded in 1989 and is headquartered in Garden City New York.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
86.7%1 month
81.6%3 months
89.2%6 months
85.1%-
10.09
1.04
0.61
0.29
2.45
3.94
-
-27.01M
46.93M
46.93M
-
-316.37
-95.20
-81.30
-50.92
7.25
1.61
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.56
Range1M
1.00
Range3M
1.74
Rel. volume
0.18
Price X volume
14.69K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
TherapeuticsMD Inc | TXMD | Drug Manufacturers - Major | 1.6425 | 18.94M | -0.45% | n/a | 27.44% |
NanoViricides Inc | NNVC | Drug Manufacturers - Major | 1.47 | 17.37M | -1.34% | n/a | 0.00% |
China Pharma Holdings Inc | CPHI | Drug Manufacturers - Major | 0.2489 | 4.27M | -3.15% | n/a | 54.76% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Pioneer Power Solutions Inc | PPSI | Electronic Components | 4.6 | 50.22M | -1.50% | n/a | 5.34% |
RF Industries Ltd | RFIL | Electronic Components | 4.1 | 43.02M | 2.50% | n/a | 85.97% |
Interlink Electronics Inc | LINK | Electronic Components | 3.6861 | 36.78M | 0.19% | n/a | 7.29% |
The InterGroup Corporation | INTG | Real Estate Services | 16.4 | 35.87M | 7.75% | n/a | -257.98% |
Nortech Systems Incorporated | NSYS | Electronic Components | 12.3014 | 33.98M | -2.37% | 5.38 | 49.22% |
The LGL Group Inc | LGL | Electronic Components | 6.125 | 32.91M | -2.00% | 75.50 | 0.00% |
Servotronics Inc | SVT | Electronic Components | 11.875 | 30.38M | 2.90% | 39.45 | 5.92% |
Orion Energy Systems Inc | OESX | Electronic Components | 0.855 | 28.00M | 1.18% | n/a | 80.80% |
Data I/O Corporation | DAIO | Electronic Components | 2.46 | 22.72M | 0.00% | n/a | 5.72% |
CPS Technologies Corporation | CPSH | Electronic Components | 1.4001 | 20.34M | -1.40% | n/a | 1.78% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 2.45 | 20.59 | Cheaper |
Ent. to Revenue | 3.94 | 5.59 | Cheaper |
PE Ratio | - | 40.51 | - |
Price to Book | 1.04 | 11.34 | Cheaper |
Dividend Yield | - | 3.25 | - |
Std. Deviation (3M) | 89.24 | 40.71 | Riskier |
Debt to Equity | 0.61 | 1.72 | Cheaper |
Debt to Assets | 0.29 | 0.31 | Par |
Market Cap | 46.93M | 199.23B | Emerging |